Top Markets
#1 NEW X CEO IS BACK NEW X CEO IS BACK +190,916.81%
#2 Beta Finance Beta Finance +8,977.34%
#3 Velas Velas +461.19%
#4 Tribe Tribe +73.83%
#5 Orochi Network Orochi Network +51.29%
#6 Chainbase Chainbase +40.86%
#7 BabyBoomToken BabyBoomToken +34.51%
#8 Freysa AI Freysa AI +33.79%
#9 Block Street Block Street +28.93%
#10 Chrema Coin Chrema Coin +27.48%
Coin of the day
NEW X CEO IS BACK NEW X CEO IS BACK
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Nuformix plc Nuformix plc

Nuformix plc

NFX
Hisse Senetlerindeki Sıralama #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Hisse Fiyatı
$0.00244926
Piyasa Değeri
$51.67K
Değişim (1 gün)
5.88%
Değişim (1 yıl)
110.15%
Ülke
GB
Ticaret Nuformix plc (NFX)

Kategori

Healthcare
Nuformix plc (NFX) için P/B oranı
March 2026 itibarıyla P/B oranı TTM: 5.52
Nuformix plc şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) 5.52'dir. 2024 yılının sonunda şirketin P/B oranı 0.64 idi.
Nuformix plc için P/B oranı geçmişi 2014 - 2026 arası
Her yılın sonunda P/B oranı
Yıl P/B Oranı Değiştir
2026 (TTM) 5.52 6.74%
2025 5.17 703.62%
2024 0.64 44.29%
2023 0.45 -63.79%
2022 1.23 -46.40%
2021 2.30 -42.90%
2020 4.02 28.15%
2019 3.14 93.67%
2018 1.62 -108.69%
2017 -18.66 -793.31%
2016 2.69 0.00%
2014 0.00 0.00%
Benzer şirketler veya rakipler için P/B oranı
Şirket P/B Oranı P/B Oranı Farkı Ülke
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5.6573 2.51%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3842 15.68%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.4551 -55.51%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.364 -20.92%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5504 -53.79%
AU